Patents-Review.com
🔗 Permalink
Assignee profile:

PHIGENIX, INC.

City:

Atlanta, Georgia

Country:

United States

Published Applications:

24

Last publication date:

2014-11-13

Patent Grants:

13

Last grant date:

2014-05-13

Top Inventors for applications by PHIGENIX, INC.

These are the the leading inventors for applications assigned to PHIGENIX, INC.:

Recent patent applications by PHIGENIX, INC.

PHIGENIX, INC. based in Atlanta, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-11-13
US20140336130A1
Chemistry; metallurgy

TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS

 #2 | 2014-05-15
US20140135378A1
Human necessities

TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS

 #3 | 2013-11-07 ✅ Patent 8,722,643 granted on 2014-05-13
US20130296403A1
Human necessities

Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions

 #4 | 2013-01-24 ✅ Patent 8,623,617 granted on 2014-01-07
US20130023425A1
Chemistry; metallurgy

Detecting PAX2 for the diagnosis of breast cancer

 #5 | 2013-01-24 ✅ Patent 8,722,367 granted on 2014-05-13
US20130023424A1
Chemistry; metallurgy

Detecting PAX2 for the diagnosis of breast cancer

 #6 | 2012-06-21 ✅ Patent 8,461,126 granted on 2013-06-11
US20120157508A1
Human necessities

Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions

 #7 | 2012-03-22
US20120071347A1
Human necessities

COMPOSITIONS AND METHODS FOR MONITORING AND DETECTING CANCEROUS CONDITIONS

 #8 | 2012-03-08 ✅ Patent 8,445,444 granted on 2013-05-21
US20120058130A1
Chemistry; metallurgy

Compositions and methods for diagnosing, treating, and preventing prostate conditions

 #9 | 2011-12-29 ✅ Patent 8,653,021 granted on 2014-02-18
US20110318338A1
Human necessities

Targeting PAX2 for the treatment of breast cancer

 #10 | 2011-10-06
US20110243937A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #11 | 2011-09-29 ✅ Patent 8,431,546 granted on 2013-04-30
US20110236403A1
Chemistry; metallurgy

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

 #12 | 2011-09-22
US20110229492A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING, AND PREVENTING PROSTATE CONDITIONS

 #13 | 2011-09-22
US20110229468A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #14 | 2011-09-22
US20110229467A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #15 | 2011-09-15 ✅ Patent 8,461,101 granted on 2013-06-11
US20110223162A1
Human necessities

Targeting PAX2 for the treatment of breast cancer

 #16 | 2011-09-15 ✅ Patent 8,633,149 granted on 2014-01-21
US20110223161A1
Human necessities

Targeting PAX2 for the treatment of breast cancer

 #17 | 2011-09-08 ✅ Patent 8,394,780 granted on 2013-03-12
US20110217299A1
Human necessities

Targeting PAX2 for the treatment of breast cancer

 #18 | 2011-09-01
US20110212089A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #19 | 2011-08-25
US20110206666A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #20 | 2011-08-25
US20110206665A1
Human necessities

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #21 | 2011-07-21 ✅ Patent 8,735,365 granted on 2014-05-27
US20110178162A1
Chemistry; metallurgy

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

 #22 | 2010-08-19 ✅ Patent 8,080,534 granted on 2011-12-20
US20100209421A1
Human necessities

Targeting PAX2 for the treatment of breast cancer

 #23 | 2010-02-04 ✅ Patent 8,088,603 granted on 2012-01-03
US20100029560A1
Chemistry; metallurgy

Compositions and methods for diagnosing, treating, and preventing prostate conditions

 #24 | 2010-02-04
US20100029504A1
Chemistry; metallurgy

DETECTING PAX2 FOR THE DIAGNOSIS OF BREAST CANCER

Also check out Phigenix, Inc.'s (Atlanta, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

6071 ⎘